Introduction: Pseudomonas aeruginosa is the most commonly isolated pathogen in
bronchiectasis and is associated with worse outcomes. Eradication treatment is …

Bronchiectasis and nontuberculous mycobacteria (NTM) are intricately intertwined, with
NTM capable of being both a cause and consequence of bronchiectatic disease. This …

Background International guidelines recommend airway clearance management as one of
the important pillars of bronchiectasis treatment. However, the extent to which airway …

Background Chronic lung infection with Pseudomonas aeruginosa is associated with
increased exacerbations and mortality in people with bronchiectasis. The PROMIS-I and …

Extract For people with bronchiectasis, achieving long-term adherence to physiotherapy
strategies is a major challenge. The regular use of airway clearance techniques (ACTs) …

Background A validated 4-point sputum colour chart can be used to objectively evaluate the
levels of airway inflammation in bronchiectasis patients. In the European Bronchiectasis …

Rationale: Chest computed tomography (CT) scans are essential to diagnose and monitor
bronchiectasis (BE). To date, few quantitative data are available about the nature and extent …

Background Using treatable traits as a management approach in bronchiectasis involves
determining identifiable, clinically relevant, measurable and treatable problems to develop a …

Extract It is our pleasure to introduce a review series in the European Respiratory Review for
the World Bronchiectasis Conference 2024, covering key clinical topics and perspectives for …

Formerly regarded as a rare disease, bronchiectasis is increasingly recognised. A renewed
interest in this disease has led to significant progress in bronchiectasis research …